CRGX — CARGO Therapeutics Balance Sheet
0.000.00%
- $219.57m
- -$32.99m
- 42
- 38
- 21
- 24
Annual balance sheet for CARGO Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 0.041 | 1.87 | 406 | 340 |
| Net Total Receivables | 0 | 0.476 | 1.74 | 2.04 |
| Prepaid Expenses | ||||
| Total Current Assets | 0.184 | 3.93 | 409 | 345 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 3.88 | 5.53 | 38.6 | 34.8 |
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 4.5 | 10.2 | 453 | 414 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 2.45 | 44.1 | 21.2 | 25 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 4.68 | 45.5 | 47.6 | 53.8 |
| Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -0.175 | -35.2 | 405 | 360 |
| Total Liabilities & Shareholders' Equity | 4.5 | 10.2 | 453 | 414 |
| Total Common Shares Outstanding |